Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

MediWound Ltd.

Initiate the pharmacology clinical study

Not delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
11 Jan 2021
Due
30 Jun 2021
Checked
24 Oct 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“preparing to initiate this study in the first half of 2021”

What we found

Evidence strength A What the grades mean

The company did not initiate the pharmacology study by the first half of 2021; filings indicate the study was ongoing later in 2021, with initial data announced in December 2021.

  • A
    MediWound Ltd. 6-K filed 2021-08-10 Regulatory filing · published 10 Aug 2021 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 3dc3db32e05c
    “we look forward to additional significant clinical milestones in the months ahead as we complete enrollment in our phase II study and generate data from our phase II pharmacology study later this year.” ✓ confirmed on the page
  • A
    MediWound Ltd. 20-F filed 2022-03-17 Regulatory filing · published 17 Mar 2022 · retrieved 24 Oct 2026 · kept permanently by the SEC · fingerprint 04964b6b2869
    “In addition, in December 2021, we announced positive initial data from our ongoing open-label, phase 2 pharmacology study of EscharEx” ✓ confirmed on the page

Market reaction: the shares moved -1.8% against the S&P 500 over the three sessions around the disclosure (16 Mar 2022 to 21 Mar 2022). What this measures

Checked 24 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Initiate
Deliverable
pharmacology clinical study
In the company’s control
High
Specificity
High
Depends on
Customer

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “no_evidence”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you MediWound Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-MDWD-021500 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.